Competitive advantage of hypervirulent Group B Streptococcus for neonatal colonization revealed by metagenomic analysis of gut microbiota
Anne‐Sophie Alvarez, Florian Plaza Oñate, Gérald Touak, Sean Kennedy, François Goffinet, Céline Plainvert, Laurent Mandelbrot, Stanislav Dusko Ehrlich, Claire Poyart, Asmaa Tazi
The paper identifies GBS CC17's competitive advantage over non-CC17 GBS in neonatal gut colonization through metagenomic analysis and in vitro experiments.
bioRxiv · Jun 19, 2026 · PreprintMicrobiology